In 2013, Kong et al found that HE4 could inhibit the proliferation abilities of ovarian cancer cells through MAPK and PI3K/AKT signaling pathway, but had no effect on EGFR phosphorylation 35. This evidence concerns the gene EGFR and ovarian carcinoma.